|
AFRICAN FEMALE BREAST CANCER EPIDERMIOLOGY (AFBRECANE) STUDY
|
U01HG009784-01
|
$85,000
|
|
Adebamowo, Clement
|
INSTITUTE OF HUMAN VIROLOGY
|
|
Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells
|
2R01CA134633-05
|
$540,493
|
|
AHRENS, ERIC
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Protease activated receptor-2 (PAR-2) signaling and metastatic ovarian cancer
|
1R01CA196988-01A1
|
$353,419
|
|
ANTALIS, TONI
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Deciphering the tumor suppressive functions of macroH2A
|
2R01CA154683-06
|
$439,563
|
|
BERNSTEIN, EMILY
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
An assessment of whether aspirin and/or vitamin D improves breast cancer outcomes in Black women and the modifying effect of genetic variants
|
1K01CA212056-01A1
|
$133,106
|
|
BETHEA, TRACI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Imaging tumor and T cell responses to metabolic and immune modulation therapy
|
1R01CA215136-01A1
|
$712,992
|
|
BLASBERG, RONALD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Improving anti-tumor T cell immunity by targeting LDH-A functions beyond the
|
1R01CA212605-01A1
|
$536,535
|
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Developing a Human in Mouse Cancer Model with a Completely Humanized Stroma
|
1R01CA211913-01A1
|
$681,408
|
|
BUCKANOVICH, RONALD
|
MAGEE-WOMEN'S RES INST AND FOUNDATION
|
|
Insulin Resistance
|
ZIA CP010136-10798
|
$134,022
|
$13,402
|
Caporaso, Neil
|
DCEG (NCI)
|
|
The role of PLAG1 in Wilms tumor formation
|
1K08CA207849-01A1
|
$157,185
|
|
CHEN, KENNETH
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Mechanistic study on synergistic photo-immunological effects of laser immunotherapy for metastatic cancers
|
1R01CA205348-01A1
|
$274,871
|
|
CHEN, WEI
|
UNIVERSITY OF CENTRAL OKLAHOMA
|
|
Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance
|
1R01CA208100-01A1
|
$498,613
|
|
CHEN, YU
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Targeting c-Myc and Proteasome Inhibitor Resistance in Multiple Myeloma
|
1R01CA212119-01A1
|
$580,951
|
|
CHEN, YUAN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Precision nanotherapeutics for cancer treatment
|
1R01CA207584-01A1
|
$412,532
|
|
CHENG, JIANJUN
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
Characterization of CD99 as a Therapeutic Target in the Myelodysplastic Syndromes and Acute Myeloid Leukemia
|
1K08CA194275-01A1
|
$177,336
|
|
CHUNG, STEPHEN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Distance Education to Engage Alaskan Community Health Aides in Cancer Control
|
5R25CA186882-04
|
$160,384
|
$160,384
|
CUEVA, MELANY
|
ALASKA NATIVE TRIBAL HEALTH CONSORTIUM
|
|
Using Context to Improve Implementation of Evidenced-based Interventions for Colorectal Cancer Screening in Rural Primary Care (Precise CRC)
|
1K07CA211971-01A1
|
$170,639
|
|
DAVIS, MELINDA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S1
|
$60,000
|
$600
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S2
|
$75,000
|
$750
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S3
|
$749,911
|
$7,499
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-43
|
$5,815,389
|
$58,154
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Gut Microbiome, Antibiotic Use & Colon Cancer Recurrence
|
1R01CA207467-01A1
|
$550,130
|
|
FEDIRKO, VERONIKA
|
EMORY UNIVERSITY
|
|
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY
|
1R01CA205239-01A1
|
$614,214
|
|
FEHNIGER, TODD
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA047904-29S1
|
$115,192
|
$2,304
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-29S2
|
$55,932
|
$1,119
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-29S3
|
$175,000
|
$3,500
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
5P30CA047904-29
|
$5,129,654
|
$102,593
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Nuclear receptor regulation of a breast cancer stem cell population
|
5F31CA210519-02
|
$34,861
|
|
FETTIG ANDERSON, LYNSEY
|
UNIVERSITY OF COLORADO DENVER
|
|
Young Minority Scientists in the Field of Cancer
|
5R13CA040577-31
|
$69,443
|
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Targeting TDO2 as a mediator of T-cell function in triple-negative breast cancer
|
5F31CA203486-02
|
$32,473
|
|
GREENE, LISA
|
UNIVERSITY OF COLORADO DENVER
|
|
Genetic Analysis of Breast Cancer Progression in Mice Using Inducible Transposition
|
1R01CA212584-01A1
|
$351,851
|
|
GUNTHER, EDWARD
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer
|
1U01CA213285-01A1
|
$558,611
|
|
HANASH, SAMIR
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment
|
1R01CA212190-01A1
|
$471,490
|
|
HARDY, KRISTINA
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Blood and Marrow Transplant Clinical Trials Network Data Coordinating Center
|
U24HL138660-01
|
$3,900,000
|
|
Horowitz, Mary
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Role and targeting of PRMT5 in prostate cancer
|
1R01CA212403-01A1
|
$547,569
|
|
HU, CHANG-DENG
|
PURDUE UNIVERSITY
|
|
Optimizing the Treatment of Pancreatic Adenocarcinoma
|
1R01CA212086-01A1
|
$398,519
|
|
HUR, CHIN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Improving Adherence to Endocrine Therapy in Breast Cancer Survivors
|
1K07CA211107-01A1
|
$164,422
|
|
JACOBS, JAMIE
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Development of an autologous humanized model of melanoma exploring human thymic education capacity
|
1R01CA213102-01A1
|
$580,793
|
|
JIMENO, ANTONIO
|
UNIVERSITY OF COLORADO DENVER
|
|
Role of Insulin Receptor Substrates in Kras-driven lung cancer
|
1R01CA211944-01A1
|
$404,888
|
|
KALAANY, NADA
|
BOSTON CHILDREN'S HOSPITAL
|
|
Role of MAST1 kinase in cisplatin resistant cancers
|
1R01CA207768-01A1
|
$356,850
|
|
KANG, SUMIN
|
EMORY UNIVERSITY
|
|
Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer
|
1R01CA213119-01A1
|
$504,040
|
|
KASAHARA, NORIYUKI
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Exploring the Role of Mitochondrial Fission in Pancreatic Tumorigenesis
|
3R01CA200755-02S1
|
$191,853
|
|
KASHATUS, DAVID
|
UNIVERSITY OF VIRGINIA
|
|
Proteasome inhibitors for the treatment of solid tumors
|
1R01CA213223-01A1
|
$381,450
|
|
KISSELEV, ALEXEI
|
AUBURN UNIVERSITY AT AUBURN
|
|
Notch signaling in liposarcoma
|
1R01CA212609-01A1
|
$354,563
|
|
KUANG, SHIHUAN
|
PURDUE UNIVERSITY
|
|
Targeting microRNAs to eradicate leukemia stem cells
|
1R01CA205247-01A1
|
$434,503
|
|
KUO, YA-HUEI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Oncogenic pathways and therapeutic targets in T cell acute lymphoblastic leukemia
|
1R01CA211734-01A1
|
$391,163
|
|
LANGENAU, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Understanding Ethnic Differences in Cancer: The Multiethnic Cohort Study
|
2U01CA164973-06
|
$3,176,130
|
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Stress Induction of Glucose Regulated Protein GRP78/BiP
|
2R01CA027607-37A1
|
$393,619
|
|
LEE, AMY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Mechanism and Regulation of Human Nonhomologous DNA End Joining
|
2R01CA100504-14A1
|
$391,875
|
|
LIEBER, MICHAEL
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
RON Receptor in Pancreatic Cancer Biology and Therapy
|
2R01CA155620-06A1
|
$306,943
|
|
LOWY, ANDREW
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
Total relevant funding to Arctic for this search: $1,400,837
|